| Application no. and date | 19856433.8 (espacenet) (Federated) (European Patent Register), 20190903 | | Patent/reg. no. and date | DK/EP 3843759, 20240214 | | Publication date | 20210707 | | Priority no. and date | US 201862725976 P, 20180831, US 201862726919 P, 20180904 | | EP pub. no. and date |
EP 3843759 20210707 | | Effective date | | | Applicant/owner | Iovance Biotherapeutics, Inc., 825 Industrial Road
Suite 400
San Carlos, CA 94070, US | | Applicant ref. no. | V2404-041-DK | | Inventor | FARDIS, Maria, 105 Aberdeen Drive
San Carlos, CA 94070, US,
NATARAJAN, Arvind, 174 Smoke Rise Road
Basking Ridge, NJ 07920, US | | Representative | NORDIC PATENT SERVICE A/S, Bredgade 30, 1260 København K | | Opponent | | | IPC Class | A61K 35/17 (2015.01) , A61K 45/06 (2006.01) , A61P 35/00 (2006.01) , C12N 5/0781 (2010.01) , C12N 5/0783 (2010.01) | | Title | ANVENDELSE AF TUMORINFILTRERENDE LYMFOCYTTER TIL BEHANDLING AF PATIENTER MED NSCLC, DER ER REFRAKTÆRE OVER FOR ANTI-PD-1-ANTISTOF | | Int. application no. | US2019049384 | | Int. publication no. | WO2020096682 | | Related patent (certificate) | | | Status | Rettet DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
